HOME
Vol , Issue
Date of Publication: October 01, 2011
DOI: https://doi.org/10.20529/IJME.2011.082
Views
, PDF Downloads:
Research Articles
A study of warning letters issued to clinical investigators and institutional review boards by the United States Food and Drug Administration
Abstract:
Background: Warning letters (WLs) issued by the US FDA (United States Food and Drug Administration) mention the nature of violations by clinical investigators and institutional review boards (IRBS) and can help as training tools.
Copyright and license ©Indian Journal of Medical Ethics 2016: Open Access and Distributed under the Creative Commons license ( CC BY-NC-ND 4.0), which permits only non-commercial and non-modified sharing in any medium, provided the original author(s) and source are credited.
